98 related articles for article (PubMed ID: 12574788)
1. Bone mass and bone modelling markers in hypertensive postmenopausal women.
Pérez-Castrillón JL; Justo I; Silva J; Sanz A; Igea R; Escudero P; Pueyo C; Diaz C; Hernández G; Dueñas A
J Hum Hypertens; 2003 Feb; 17(2):107-10. PubMed ID: 12574788
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin and bone mass in postmenopausal hypertensive women.
Pérez-Castrillón JL; Justo I; Sanz A; San Miguel A; Mazón MA; Abad L; Vega G; Dueñas A
Ann Nutr Metab; 2007; 51(3):223-7. PubMed ID: 17587793
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
4. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
Uemura H; Yasui T; Miyatani Y; Yamada M; Hiyoshi M; Arisawa K; Irahara M
Menopause; 2008; 15(1):180-4. PubMed ID: 17545921
[TBL] [Abstract][Full Text] [Related]
5. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
6. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and bone turnover in postmenopausal women treated for breast cancer.
Waltman NL; Ott CD; Twiss JJ; Gross GJ; Lindsey AM; Moore TE
Cancer Nurs; 2008; 31(3):182-90. PubMed ID: 18453874
[TBL] [Abstract][Full Text] [Related]
8. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
[TBL] [Abstract][Full Text] [Related]
9. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women.
Dai Y; Shen L
Chin Med J (Engl); 2007 Nov; 120(22):2017-21. PubMed ID: 18067789
[TBL] [Abstract][Full Text] [Related]
10. Effects of skeletal size of the lumbar spine on areal bone density, volumetric bone density, and the diagnosis of osteoporosis in postmenopausal women in China.
Liao EY; Wu XP; Liao HJ; Zhang H; Peng J
J Bone Miner Metab; 2004; 22(3):270-7. PubMed ID: 15108071
[TBL] [Abstract][Full Text] [Related]
11. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
12. [Urinary calcium and bone turnover markers].
de la Torre Vega JP; Amador Licona N; Zamora Mata L; Morales Ramos Ael J
Ginecol Obstet Mex; 2004 Jan; 72(1):23-8. PubMed ID: 15239561
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
14. The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women.
Pongchaiyakul C; Kosulwat V; Charoenkiatkul S; Chailurkit LO; Rojroongwasinkul N; Rajatanavin R
J Med Assoc Thai; 2008 Mar; 91(3):295-302. PubMed ID: 18575280
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
16. High blood pressure, bone-mineral loss and insulin resistance in women.
Gotoh M; Mizuno K; Ono Y; Takahashi M
Hypertens Res; 2005 Jul; 28(7):565-70. PubMed ID: 16335884
[TBL] [Abstract][Full Text] [Related]
17. Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS).
Kemmler W; Lauber D; Weineck J; Hensen J; Kalender W; Engelke K
Arch Intern Med; 2004 May; 164(10):1084-91. PubMed ID: 15159265
[TBL] [Abstract][Full Text] [Related]
18. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
19. Predicting bone mineral density of postmenopausal healthy and cirrhotic Italian women using age and body mass index.
Mohamed EI; Tarantino U; Promenzio L; De Lorenzo A
Acta Diabetol; 2003 Oct; 40 Suppl 1():S23-8. PubMed ID: 14618428
[TBL] [Abstract][Full Text] [Related]
20. Body composition, bone mineral density, and circulating leptin levels in postmenopausal Turkish women.
Sahin G; Polat G; Baethiş S; Milcan A; Baethdatoethlu O; Erdoethan C; Camdeviren H
Rheumatol Int; 2003 Mar; 23(2):87-91. PubMed ID: 12634942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
